A recent outbreak of Nipah virus has occurred in West Bengal, India, with confirmed cases including healthcare workers. The World Health Organization (WHO) has listed Nipah virus as a "priority pathogen with pandemic potential" on its high-priority watchlist.

In response to the urgent demand of this outbreak, XABT took immediate action and donated Nipah virus detection kits free of charge to dozens of hospitals.

Lethal Risk: High Threat with 40%-75% Case Fatality Rate

Nipah virus has an approximate case fatality rate of 40%-75%. Currently, there are no approved vaccines or specific antiviral treatments for Nipah virus globally. Clinical management relies solely on supportive care, resulting in an extremely high risk of severe illness and death.

The virus can simultaneously attack the lungs and the central nervous system. Even among survivors, approximately 20% may suffer permanent neurological damage such as epilepsy and cognitive impairment.

Diverse Transmission Routes: Hidden Risks in Multiple Forms

The transmission chain of Nipah virus is complex, making prevention and control relatively challenging:

· Natural Host: The natural reservoir is fruit bats, whose saliva, urine, and feces can contaminate food and the environment.

· Primary Human Infection Routes: Consumption of contaminated food such as raw date palm sap or palm juice; direct contact with infected livestock (e.g., pigs, horses) or their bodily fluids.

· Confirmed Human-to-Human Transmission: Close contact with patients or their bodily fluids (e.g., nasopharyngeal secretions, blood, urine) in household care or medical settings may lead to infection.

Latency and Camouflage: Key Hidden Danger of Misdiagnosis

The stealth nature of Nipah virus further amplifies transmission risks:

1. Extremely Long Incubation Period: Typically 4-14 days, with a maximum of 45 days. Infected individuals may be asymptomatic during incubation but can still act as a source of transmission.

2. Early Symptoms Mimic Common Influenza: Only presenting as fever, headache, myalgia, etc., which are easily misdiagnosed, leading to missed opportunities for optimal prevention and control.As the disease progresses, it can rapidly cause fatal encephalitis and acute respiratory distress syndrome. Some patients fall into a coma within 24-48 hours, making treatment extremely difficult.

Lethal Risk: High Threat with 40%-75% Case Fatality Rate

Against the backdrop of Nipah virus with high lethality and stealth, "early detection" is the core prerequisite for blocking transmission.

Scenarios such as port entry quarantine, medical institution screening, and CDC emergency monitoring all require detection products with high sensitivity, rapid results, and multi-scenario adaptability to identify infections and lock in at-risk populations in a timely manner.

As a leading core supplier of PCR reagents in China, XABT took immediate action and donated Nipah virus detection kits free of charge to dozens of hospitals, helping medical institutions quickly carry out virus screening and build the first line of defense for epidemic prevention and control.

Relying on profound technical accumulation, XABT has developed a mature detection solution for Nipah virus. Meanwhile, the company has a professional technical service team with 24-hour emergency supply capacity, which can provide solid product and service support for timely blocking the epidemic transmission chain.

From technological research and development to public welfare assistance, from rapid response to efficient supply, XABT has always practiced social responsibility with professional strength, guarded human health with scientific and technological innovation, and contributed the responsibility and commitment of a Chinese IVD enterprise to global infectious disease prevention and control.